【德国诊断产品开发商】Anbio Biotechnology（NNNN）美股IPO招股说明书（修订版）（英文版）（152页）.pdf

1、F-1/A 1 ea0200357-11.htm REGISTRATION STATEMENTAs filed with the U.S.Securities and Exchange Commission on January 10,2025.Registration No.333-284106UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549_Amendment No.1toFORM F-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933_Anbio

2、 Biotechnology(Exact Name of Registrant as Specified in its Charter)_Not Applicable(Translation of Registrants name into English)_Cayman Islands 2835 N/A(State or OtherJurisdiction ofIncorporation orOrganization)(Primary StandardIndustrialClassification Code Number)(I.R.S.EmployerIdentification No.)

3、Wilhelm Gutbrod Str 21B,60437,Frankfurt am Main,Germany+49 16 0962 47281(Address,includingzipcode,andtelephonenumber,includingareacode,ofRegistrantsprincipalex_C T Corporation System128 Liberty StreetNew York,NY 10005+1-212-894-8940(Name,address,including zip code,and telephone number,including area

4、 code,ofagent for service)_Copies to:William S.Rosenstadt,Esq.Mengyi“Jason”Ye,Esq.Yarona L.Yieh,Esq.Ortoli Rosenstadt LLP366 Madison Avenue,3rdFloorNewYork,NY10017T:212-588-0022 Tony Liu,Esq.Focus Law4501 E La Palma Ave,230Anaheim,CA 92807T:714-415-2007_Approximate date of commencement of proposed s

5、ale to the public:As soon as practicableafter effectiveness of this registration statement.If any of the securities being registered on this Form are to be offered on a delayed or continuousbasis pursuant to Rule415 under the Securities Actof1933,check the following box.If this Form is filed to regi

6、ster additional securities for an offering pursuant toRule 462(b)under the Securities Act,check the following box and list the Securities Actregistration statement number of the earlier effective registration statement for the same offering.If this Form is a post-effective amendment filed pursuant t